Apis Capital Advisors’s CAS Medical Systems, Inc. CASM Stock Holding History

Apis Capital Advisors’s Portfolio CASM Stock Details CASM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-110,000	Closed	-$176K	–	33
2018 Q4	$176K	Buy	+110,000	New	+$205K	0.24%	25
2015 Q3	$41K	Hold	33,000	–	–	0.06%	43
2015 Q2	$42K	Hold	33,000	–	–	0.05%	42
2015 Q1	$44K	Buy	33,000 +16,000	+94%	+$23.1K	0.06%	41
2014 Q4	$28K	Buy	+17,000	New	+$30.1K	0.03%	38

Other funds holding CASM

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HCMT

Highland Capital Management (Texas) Dallas, Texas $39M AUM

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

SAM

SignalPoint Asset Management Springfield, Missouri $411M AUM 23.81% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Apis Capital Advisors's CASM Position: Q1 2019 in Review

Apis Capital Advisors sold out of CAS Medical Systems, Inc. (CASM) in Q1 2019, closing a stake of 110,000 shares — an estimated $176K sold.

Apis Capital Advisors first reported a position in CASM in Q4 2014 and held it in 5 quarters. The position peaked at $176K in Q4 2018. 32 funds tracked by Wall St. Rank hold CASM as of Q1 2019.

Apis Capital Advisors reported no remaining CAS Medical Systems, Inc. position as of Q1 2019 after selling out during the quarter.
Apis Capital Advisors sold 110,000 CAS Medical Systems, Inc. shares in Q1 2019, an estimated $176K.
Apis Capital Advisors first reported a position in CAS Medical Systems, Inc. in Q4 2014 and held it in 5 quarters.
Apis Capital Advisors's CAS Medical Systems, Inc. position peaked at $176K in Q4 2018.
32 funds tracked by Wall St. Rank held CAS Medical Systems, Inc. as of Q1 2019.

Based on Apis Capital Advisors's 13F filing for Q1 2019, filed 7 May 2019.